cyclic polypeptide antibiotic
Colistin
Answer
Colistin is authorised or registered in the US, the UK, Canada, Switzerland, Brazil, Serbia and Turkey: 7 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 130 registered trials, 23 of them running. Brand names on the FDA label register: Cortisporin Tc.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
130 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 5 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 65 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Authorised | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Colistin changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 130 trials
| 2022-501575-12-00 | C3601008 - A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY no status recorded · register updated 2026-09-16 |
|---|---|
| NCT06819462 | Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury currently recruiting participants · register updated 2026-09-15 |
| 2025-524657-14-00 | Comparative bioavailability study of Colistin Cyclops® administered as 3 different doses no status recorded · register updated 2026-09-14 |
| NCT07082465 | Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand running, but no longer enrolling · register updated 2026-08-14 |
| 2024-519748-34-00 | A Randomized controlled open-label phase II trial assessing the efficacy and safety of two-dosing regimens of frozen encapsulated no status recorded · register updated 2026-07-22 |
| NCT07512596 | Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pn not yet recruiting participants · register updated 2026-07-17 |
| NCT07694700 | Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety. running, but no longer enrolling · register updated 2026-07-14 |
| NCT06087536 | A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex currently recruiting participants · register updated 2026-07-02 |
| NCT07671755 | Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pne completed · register updated 2026-06-26 |
| NCT07668141 | Colistin Nephrotoxicity and Role of Alpha Lipoic Acid not yet recruiting participants · register updated 2026-06-25 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.